123 related articles for article (PubMed ID: 37104657)
21. Comparison of clozapine use in Maryland and in Victoria, Australia.
Conley RR; Kelly DL; Lambert TJ; Love RC
Psychiatr Serv; 2005 Mar; 56(3):320-3. PubMed ID: 15746507
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
[TBL] [Abstract][Full Text] [Related]
23. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014.
Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D
Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067
[TBL] [Abstract][Full Text] [Related]
24. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
Davis MC; Fuller MA; Strauss ME; Konicki PE; Jaskiw GE
Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466
[TBL] [Abstract][Full Text] [Related]
25. The impact of clozapine initiation and cessation on psychiatric hospital admissions and bed days: a mirror image cohort study.
Siskind D; Reddel T; MacCabe JH; Kisely S
Psychopharmacology (Berl); 2019 Jun; 236(6):1931-1935. PubMed ID: 30715572
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis examining the epidemiology of clozapine-associated neutropenia.
Myles N; Myles H; Xia S; Large M; Kisely S; Galletly C; Bird R; Siskind D
Acta Psychiatr Scand; 2018 Aug; 138(2):101-109. PubMed ID: 29786829
[TBL] [Abstract][Full Text] [Related]
28. Patterns of clozapine prescribing in a mental health service in New Zealand.
Harrison J; Janlöv M; Wheeler AJ
Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
[TBL] [Abstract][Full Text] [Related]
29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
30. Antipsychotic utilisation and persistence in Australia: A nationwide 5-year study.
Taylor M; Dangelo-Kemp D; Liu D; Kisely S; Graham S; Hartmann J; Colman S
Aust N Z J Psychiatry; 2022 Sep; 56(9):1155-1163. PubMed ID: 34657454
[TBL] [Abstract][Full Text] [Related]
31. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
[TBL] [Abstract][Full Text] [Related]
32. Converting patients from brand-name clozapine to generic clozapine.
Sajbel TA; Carter GW; Wiley RB
Ann Pharmacother; 2001 Mar; 35(3):281-4. PubMed ID: 11261523
[TBL] [Abstract][Full Text] [Related]
33. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
34. Clozapine for Treatment-Refractory Behavioral Disturbance in Dementia.
Teodorescu A; Dima L; Ifteni P; Rogozea LM
Am J Ther; 2018; 25(3):e320-e325. PubMed ID: 29401113
[TBL] [Abstract][Full Text] [Related]
35. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome with clozapine: comparison of patients continuing and discontinuing treatment.
Laker MK; Duffett RS; Cookson JC
Int Clin Psychopharmacol; 1998 Mar; 13(2):75-8. PubMed ID: 9669187
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and Reports.
Lally J; Al Kalbani H; Krivoy A; Murphy KC; Gaughran F; MacCabe JH
J Clin Psychopharmacol; 2018 Oct; 38(5):520-527. PubMed ID: 30059436
[TBL] [Abstract][Full Text] [Related]
38. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Temmingh HS; Williams T; Siegfried N; Stein DJ
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
[TBL] [Abstract][Full Text] [Related]
39. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
40. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
Taylor DM; Young C; Paton C
J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
